| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRB3 CACNA1A SLC29A3 ABCA3 LRRC38 SLC35D2 TRPC1 MFSD9 GRIA3 GJC2 ANO10 PKDREJ SLCO6A1 ABCA8 SVOPL RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 CLN3 GLRA2 SLC22A2 PKD2 OSBPL10 TRPV4 TRPM8 SLC45A1 SLC4A4 MFSD5 SLC35A5 | 3.07e-12 | 1289 | 120 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRB3 CACNA1A SLC29A3 ABCA3 LRRC38 SLC35D2 TRPC1 MFSD9 GRIA3 GJC2 ANO10 PKDREJ SLCO6A1 ABCA8 SVOPL RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 GLRA2 SLC22A2 PKD2 TRPV4 TRPM8 SLC45A1 SLC4A4 MFSD5 SLC35A5 | 9.58e-12 | 1180 | 120 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium channel activity | 5.67e-09 | 129 | 120 | 10 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.58e-08 | 151 | 120 | 10 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.70e-08 | 31 | 120 | 6 | GO:0099604 | |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 GJC2 ANO10 PKDREJ RYR1 RYR2 ITPR1 GLRA2 PKD2 TRPV4 TRPM8 | 1.04e-07 | 525 | 120 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 GJC2 ANO10 PKDREJ RYR1 RYR2 ITPR1 GLRA2 PKD2 TRPV4 TRPM8 | 1.07e-07 | 526 | 120 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 ANO10 PKDREJ RYR1 RYR2 ITPR1 GLRA2 PKD2 TRPV4 TRPM8 | 1.10e-07 | 459 | 120 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRB3 CACNA1A LRRC38 GRIA3 ANO10 RYR1 RYR2 ITPR1 GLRA2 PKD2 TRPV4 TRPM8 | 1.12e-07 | 334 | 120 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 ANO10 PKDREJ RYR1 RYR2 ITPR1 SLC38A2 GLRA2 PKD2 TRPV4 TRPM8 SLC45A1 SLC4A4 MFSD5 | 1.29e-07 | 758 | 120 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 ANO10 PKDREJ RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 GLRA2 PKD2 TRPV4 TRPM8 SLC45A1 SLC4A4 | 2.59e-07 | 793 | 120 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.60e-07 | 193 | 120 | 10 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.15e-07 | 197 | 120 | 10 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 9.76e-07 | 172 | 120 | 9 | GO:0044325 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A LRRC38 TRPC1 GRIA3 ANO10 PKDREJ RYR1 RYR2 ITPR1 PKD2 TRPV4 TRPM8 | 1.09e-06 | 343 | 120 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A LRRC38 TRPC1 GRIA3 ANO10 PKDREJ RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 PKD2 TRPV4 TRPM8 SLC45A1 SLC4A4 | 2.33e-06 | 664 | 120 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.56e-06 | 18 | 120 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.18e-06 | 6 | 120 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A LRRC38 TRPC1 GRIA3 PKDREJ RYR1 RYR2 ITPR1 SLC38A2 PKD2 TRPV4 TRPM8 SLC4A4 | 4.56e-06 | 465 | 120 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.20e-05 | 140 | 120 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A LRRC38 TRPC1 GRIA3 PKDREJ RYR1 RYR2 ITPR1 SLC38A2 PKD2 TRPV4 TRPM8 SLC45A1 SLC4A4 | 2.45e-05 | 627 | 120 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.44e-05 | 33 | 120 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 4.48e-05 | 12 | 120 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC29A3 ABCA3 SLC35D2 SLCO6A1 ABCA8 SLC38A2 ATP8A1 SLC22A2 SLC45A1 SLC4A4 SLC35A5 | 1.44e-04 | 477 | 120 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.84e-04 | 196 | 120 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.13e-04 | 4 | 120 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.31e-04 | 50 | 120 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 3.54e-04 | 5 | 120 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.83e-04 | 57 | 120 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.37e-04 | 59 | 120 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.37e-04 | 59 | 120 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.67e-04 | 60 | 120 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.90e-04 | 171 | 120 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.33e-04 | 65 | 120 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.33e-04 | 65 | 120 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | protein domain specific binding | MYO1D FZD3 NDFIP2 LAMP2 YWHAB YWHAE YWHAH LPAR1 YWHAZ ITPR1 PHAF1 PKD2 TRPV4 YWHAQ | 7.79e-04 | 875 | 120 | 14 | GO:0019904 |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 9.79e-04 | 8 | 120 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.03e-03 | 74 | 120 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.09e-03 | 75 | 120 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.11e-03 | 34 | 120 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.20e-03 | 77 | 120 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 1.56e-03 | 10 | 120 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.74e-03 | 211 | 120 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.80e-03 | 86 | 120 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | UDP-xylosyltransferase activity | 1.90e-03 | 11 | 120 | 2 | GO:0035252 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 1.90e-03 | 11 | 120 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | xylosyltransferase activity | 1.90e-03 | 11 | 120 | 2 | GO:0042285 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.90e-03 | 11 | 120 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.20e-03 | 151 | 120 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 2.27e-03 | 12 | 120 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE17 SPDYE10 SPDYE12 YWHAZ RYR2 SPDYE11 SPDYE15 NBEAL2 SPDYE8 TRPV4 YWHAQ FERMT2 SPDYE14 | 2.28e-03 | 873 | 120 | 13 | GO:0019901 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.66e-03 | 46 | 120 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 2.68e-03 | 13 | 120 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.69e-03 | 230 | 120 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.98e-03 | 162 | 120 | 5 | GO:0099106 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 3.01e-03 | 48 | 120 | 3 | GO:0008200 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 3.11e-03 | 14 | 120 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.11e-03 | 14 | 120 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.11e-03 | 14 | 120 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.12e-03 | 100 | 120 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | peptide binding | 3.12e-03 | 318 | 120 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 3.38e-03 | 50 | 120 | 3 | GO:0016248 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.47e-03 | 103 | 120 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 3.57e-03 | 51 | 120 | 3 | GO:0141110 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.57e-03 | 51 | 120 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.57e-03 | 15 | 120 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 3.98e-03 | 53 | 120 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | channel regulator activity | 4.04e-03 | 174 | 120 | 5 | GO:0016247 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 4.07e-03 | 16 | 120 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 4.34e-03 | 177 | 120 | 5 | GO:0141108 | |
| GeneOntologyMolecularFunction | tRNA-specific ribonuclease activity | 4.59e-03 | 17 | 120 | 2 | GO:0004549 | |
| GeneOntologyMolecularFunction | flippase activity | 4.59e-03 | 17 | 120 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 5.15e-03 | 18 | 120 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 5.46e-03 | 117 | 120 | 4 | GO:0051219 | |
| GeneOntologyMolecularFunction | kinase binding | SPDYE17 SPDYE10 SPDYE12 YWHAZ RYR2 SPDYE11 SPDYE15 NBEAL2 SPDYE8 TRPV4 YWHAQ FERMT2 SPDYE14 | 5.51e-03 | 969 | 120 | 13 | GO:0019900 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 5.73e-03 | 19 | 120 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6.34e-03 | 20 | 120 | 2 | GO:0016894 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 6.34e-03 | 20 | 120 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.88e-03 | 125 | 120 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 6.98e-03 | 21 | 120 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.65e-03 | 22 | 120 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 7.93e-03 | 288 | 120 | 6 | GO:0016757 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRB3 CACNA1A HFE LPAR3 TSPAN18 LRRC38 TRPC1 NDFIP2 GRIA3 GJC2 ANO10 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 GLRA2 SLC22A2 PKD2 TRPV4 TRPM8 FTL YWHAQ HEPHL1 SLC4A4 MFSD5 LARGE1 | 8.65e-12 | 1374 | 114 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A HFE LPAR3 TSPAN18 LRRC38 TRPC1 NDFIP2 GJC2 ANO10 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 SLC22A2 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 LARGE1 | 3.31e-09 | 1157 | 114 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A HFE LPAR3 TSPAN18 LRRC38 TRPC1 NDFIP2 GJC2 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 LARGE1 | 2.48e-08 | 1000 | 114 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 GJC2 ANO10 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 GLRA2 PKD2 TRPV4 TRPM8 YWHAQ SLC4A4 LARGE1 | 3.71e-08 | 1115 | 114 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 4.17e-07 | 84 | 114 | 7 | GO:0051480 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GJC2 ANO10 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 GLRA2 PKD2 TRPV4 TRPM8 SLC4A4 LARGE1 | 7.00e-07 | 1017 | 114 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1A HFE TRPC1 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 1.39e-06 | 611 | 114 | 15 | GO:0030003 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1A HFE TRPC1 TMTC2 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 1.67e-06 | 705 | 114 | 16 | GO:0055080 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1A HFE TRPC1 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 1.73e-06 | 622 | 114 | 15 | GO:0006873 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A HFE TRPC1 TMTC2 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 2.08e-06 | 717 | 114 | 16 | GO:0050801 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A LRRC38 TRPC1 GJC2 ANO10 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 ATP8A1 PKD2 TRPV4 TRPM8 SLC4A4 LARGE1 | 4.05e-06 | 942 | 114 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A LPAR3 TSPAN18 TRPC1 GJC2 PKDREJ YWHAE RYR1 RYR2 ITPR1 PKD2 TRPV4 TRPM8 | 4.83e-06 | 509 | 114 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 5.17e-06 | 229 | 114 | 9 | GO:0006643 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A HFE TRPC1 TMTC2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 | 8.66e-06 | 622 | 114 | 14 | GO:0098771 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CACNA1A TRPC1 TMTC2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 | 1.06e-05 | 389 | 114 | 11 | GO:0055074 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A TRPC1 GJC2 PKDREJ YWHAE RYR1 RYR2 ITPR1 PKD2 TRPV4 TRPM8 | 1.13e-05 | 392 | 114 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 2.69e-05 | 157 | 114 | 7 | GO:0046467 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A HFE LARGE2 TRPC1 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 LARGE1 | 2.72e-05 | 981 | 114 | 17 | GO:0019725 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 3.08e-05 | 359 | 114 | 10 | GO:0006874 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A LRRC38 TRPC1 GJC2 PKDREJ YWHAE YWHAH RYR1 RYR2 ITPR1 SLC38A2 PKD2 TRPV4 TRPM8 SLC4A4 LARGE1 | 4.72e-05 | 922 | 114 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | neural nucleus development | 4.92e-05 | 72 | 114 | 5 | GO:0048857 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 5.58e-05 | 176 | 114 | 7 | GO:0006665 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 6.94e-05 | 40 | 114 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | HFE LPAR3 TSPAN18 LRRC38 TRPC1 GJC2 YWHAE YWHAH RYR2 ITPR1 PKD2 YWHAQ | 8.45e-05 | 577 | 114 | 12 | GO:0043269 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A HFE TRPC1 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 8.49e-05 | 866 | 114 | 15 | GO:0055082 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | HFE LPAR3 TSPAN18 LRRC38 TRPC1 GJC2 YWHAE YWHAH RYR2 ITPR1 PKD2 | 9.14e-05 | 493 | 114 | 11 | GO:0010959 |
| GeneOntologyBiologicalProcess | protein O-linked mannosylation | 1.49e-04 | 19 | 114 | 3 | GO:0035269 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A HFE ABCA3 TENT4B TRPC1 TMTC2 LAMP2 YWHAE RYR1 RYR2 ITPR1 CLN3 PKD2 TRPV4 TRPM8 FTL HEPHL1 SLC4A4 | 1.66e-04 | 1249 | 114 | 18 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of response to osmotic stress | 2.03e-04 | 21 | 114 | 3 | GO:0047484 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.06e-04 | 217 | 114 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.16e-04 | 154 | 114 | 6 | GO:0051928 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 2.50e-04 | 224 | 114 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | protein mannosylation | 3.46e-04 | 25 | 114 | 3 | GO:0035268 | |
| GeneOntologyBiologicalProcess | maintenance of location | 3.56e-04 | 396 | 114 | 9 | GO:0051235 | |
| GeneOntologyBiologicalProcess | mannosylation | 3.90e-04 | 26 | 114 | 3 | GO:0097502 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 4.33e-04 | 323 | 114 | 8 | GO:0051924 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 4.84e-04 | 117 | 114 | 5 | GO:0030148 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.97e-04 | 180 | 114 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 5.96e-04 | 259 | 114 | 7 | GO:0051651 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 6.24e-04 | 7 | 114 | 2 | GO:0071420 | |
| GeneOntologyBiologicalProcess | muscle cell cellular homeostasis | 6.60e-04 | 31 | 114 | 3 | GO:0046716 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 6.98e-04 | 266 | 114 | 7 | GO:0043270 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 7.26e-04 | 32 | 114 | 3 | GO:0021533 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 7.56e-04 | 74 | 114 | 4 | GO:0051932 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GABRB3 TMEM67 SLC29A3 ABCA3 MLEC NDFIP2 GRIA3 LAMP2 TLR7 CUBN SYNPR DEGS1 DIPK2A ITPR1 PHAF1 ATP8A1 CLN3 NBEAL2 SLC22A2 PKD2 SNX18 KDELR1 DOP1B | 5.02e-07 | 1307 | 114 | 23 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | GABRB3 TMEM67 SLC29A3 ABCA3 MLEC NDFIP2 GRIA3 LAMP2 TLR7 CUBN SYNPR DEGS1 DIPK2A ITPR1 PHAF1 ATP8A1 CLN3 NBEAL2 SLC22A2 PKD2 SNX18 KDELR1 DOP1B | 6.37e-07 | 1325 | 114 | 23 | GO:0012506 |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 5.06e-06 | 46 | 114 | 5 | GO:0005790 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMEM67 MLEC ELOVL1 TMTC2 HACD4 TLR7 PIGU GBA2 DEGS1 RYR1 RYR2 STT3B ITPR1 EPM2AIP1 CLN3 PKD2 KDELR1 NECAB3 TRPM8 MOGAT3 PIGM | 6.01e-06 | 1293 | 114 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMEM67 MLEC ELOVL1 TMTC2 HACD4 TLR7 PIGU GBA2 DEGS1 RYR1 RYR2 STT3B ITPR1 EPM2AIP1 CLN3 PKD2 KDELR1 NECAB3 TRPM8 MOGAT3 PIGM | 6.45e-06 | 1299 | 114 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 GRIA3 SLCO6A1 RYR1 RYR2 GLRA2 PKD2 | 7.12e-06 | 378 | 114 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMEM67 MLEC ELOVL1 TMTC2 HACD4 TLR7 PIGU GBA2 DEGS1 RYR1 RYR2 STT3B ITPR1 EPM2AIP1 CLN3 PKD2 KDELR1 NECAB3 TRPM8 MOGAT3 PIGM | 8.95e-06 | 1327 | 114 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | transporter complex | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 DMAC2 GRIA3 SLCO6A1 RYR1 RYR2 ATP8A1 GLRA2 PKD2 | 9.63e-06 | 550 | 114 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRB3 CACNA1A LRRC38 TRPC1 DMAC2 GRIA3 SLCO6A1 RYR1 RYR2 GLRA2 PKD2 | 2.89e-05 | 523 | 114 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.28e-05 | 164 | 114 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | presynapse | GABRB1 GABRB3 CACNA1A NPY5R FZD3 GRIA3 YWHAH LPAR1 SYNPR ITPR1 PHAF1 ATP8A1 CLN3 SLC22A2 KIF2C | 9.44e-05 | 886 | 114 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | autolysosome | 1.21e-04 | 18 | 114 | 3 | GO:0044754 | |
| GeneOntologyCellularComponent | cation channel complex | 3.08e-04 | 235 | 114 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | secondary lysosome | 3.75e-04 | 26 | 114 | 3 | GO:0005767 | |
| GeneOntologyCellularComponent | platelet dense granule membrane | 4.36e-04 | 6 | 114 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRB1 GABRB3 CACNA1A HFE MLEC LRRC38 TRPC1 DMAC2 GRIA3 GJC2 LAMP2 PIGU SLCO6A1 RYR1 RYR2 DIPK2A STT3B GLRA2 PKD2 | 4.59e-04 | 1498 | 114 | 19 | GO:0098796 |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 6.16e-04 | 125 | 114 | 5 | GO:0140534 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.83e-04 | 73 | 114 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 8.77e-04 | 78 | 114 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | basal part of cell | 1.11e-03 | 378 | 114 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.29e-03 | 10 | 114 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRB3 CACNA1A FZD3 GRIA3 LPAR1 ITPR1 GLRA2 SLC22A2 FAIM2 | 1.34e-03 | 583 | 114 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.65e-03 | 230 | 114 | 6 | GO:0098562 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.88e-03 | 320 | 114 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | Golgi membrane | LARGE2 SLC35D2 NDFIP2 TLR7 GBA2 DIPK2A CLN3 KDELR1 SLC35A5 DOP1B LARGE1 | 1.96e-03 | 721 | 114 | 11 | GO:0000139 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.02e-03 | 46 | 114 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | secretory granule membrane | 2.19e-03 | 329 | 114 | 7 | GO:0030667 | |
| GeneOntologyCellularComponent | oligosaccharyltransferase complex | 2.57e-03 | 14 | 114 | 2 | GO:0008250 | |
| GeneOntologyCellularComponent | late endosome membrane | 3.01e-03 | 179 | 114 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.30e-03 | 354 | 114 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.73e-03 | 57 | 114 | 3 | GO:0034707 | |
| HumanPheno | Abnormal superficial reflex | CACNA1A ELOVL1 GRIA3 GJC2 ANO10 GBA2 TSEN2 DEGS1 ITPR1 FTL LARGE1 | 1.63e-05 | 301 | 41 | 11 | HP:0031828 |
| HumanPheno | Babinski sign | CACNA1A ELOVL1 GRIA3 GJC2 ANO10 GBA2 TSEN2 DEGS1 ITPR1 FTL LARGE1 | 1.63e-05 | 301 | 41 | 11 | HP:0003487 |
| MousePheno | decreased iron level | 2.85e-05 | 98 | 85 | 6 | MP:0014542 | |
| MousePheno | abnormal iron level | 5.28e-05 | 218 | 85 | 8 | MP:0001770 | |
| MousePheno | abnormal iron homeostasis | 6.20e-05 | 223 | 85 | 8 | MP:0005637 | |
| MousePheno | abnormal circulating iron level | 7.73e-05 | 170 | 85 | 7 | MP:0004152 | |
| Domain | 14_3_3 | 1.61e-10 | 7 | 114 | 5 | SM00101 | |
| Domain | 1433_1 | 1.61e-10 | 7 | 114 | 5 | PS00796 | |
| Domain | 1433_2 | 1.61e-10 | 7 | 114 | 5 | PS00797 | |
| Domain | 14-3-3_domain | 1.61e-10 | 7 | 114 | 5 | IPR023410 | |
| Domain | 14-3-3_CS | 1.61e-10 | 7 | 114 | 5 | IPR023409 | |
| Domain | 14-3-3 | 1.61e-10 | 7 | 114 | 5 | PF00244 | |
| Domain | 14-3-3 | 4.28e-10 | 8 | 114 | 5 | IPR000308 | |
| Domain | RIH_assoc | 4.37e-06 | 6 | 114 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 4.37e-06 | 6 | 114 | 3 | IPR013662 | |
| Domain | RIH_dom | 4.37e-06 | 6 | 114 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.37e-06 | 6 | 114 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.37e-06 | 6 | 114 | 3 | IPR015925 | |
| Domain | - | 4.37e-06 | 6 | 114 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.37e-06 | 6 | 114 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 4.37e-06 | 6 | 114 | 3 | PF08709 | |
| Domain | Ion_trans_dom | 6.30e-06 | 114 | 114 | 7 | IPR005821 | |
| Domain | Ion_trans | 6.30e-06 | 114 | 114 | 7 | PF00520 | |
| Domain | MIR | 2.58e-05 | 10 | 114 | 3 | PS50919 | |
| Domain | MIR | 2.58e-05 | 10 | 114 | 3 | PF02815 | |
| Domain | MIR | 2.58e-05 | 10 | 114 | 3 | SM00472 | |
| Domain | MIR_motif | 2.58e-05 | 10 | 114 | 3 | IPR016093 | |
| Domain | Ryanrecept_TM4-6 | 1.10e-04 | 3 | 114 | 2 | IPR009460 | |
| Domain | LPA_rcpt | 1.10e-04 | 3 | 114 | 2 | IPR004065 | |
| Domain | RyR | 1.10e-04 | 3 | 114 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.10e-04 | 3 | 114 | 2 | IPR003032 | |
| Domain | GABAAb_rcpt | 1.10e-04 | 3 | 114 | 2 | IPR002289 | |
| Domain | RR_TM4-6 | 1.10e-04 | 3 | 114 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.10e-04 | 3 | 114 | 2 | IPR013333 | |
| Domain | MFS_dom | 1.72e-04 | 134 | 114 | 6 | IPR020846 | |
| Domain | GABAA/Glycine_rcpt | 3.59e-04 | 23 | 114 | 3 | IPR006028 | |
| Domain | PKD_2 | 3.65e-04 | 5 | 114 | 2 | IPR003915 | |
| Domain | PH-BEACH_dom | 1.01e-03 | 8 | 114 | 2 | IPR023362 | |
| Domain | - | 1.01e-03 | 8 | 114 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.01e-03 | 8 | 114 | 2 | PS51783 | |
| Domain | BEACH_dom | 1.29e-03 | 9 | 114 | 2 | IPR000409 | |
| Domain | NPY_rcpt | 1.29e-03 | 9 | 114 | 2 | IPR000611 | |
| Domain | BEACH | 1.29e-03 | 9 | 114 | 2 | PS50197 | |
| Domain | Beach | 1.29e-03 | 9 | 114 | 2 | PF02138 | |
| Domain | - | 1.29e-03 | 9 | 114 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.29e-03 | 9 | 114 | 2 | SM01026 | |
| Domain | Glyco_transf_8 | 1.61e-03 | 10 | 114 | 2 | PF01501 | |
| Domain | Glyco_trans_8 | 1.61e-03 | 10 | 114 | 2 | IPR002495 | |
| Domain | TRP_channel | 1.96e-03 | 11 | 114 | 2 | IPR004729 | |
| Domain | PKD_channel | 1.96e-03 | 11 | 114 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 1.96e-03 | 11 | 114 | 2 | IPR013122 | |
| Domain | SPRY | 1.99e-03 | 87 | 114 | 4 | SM00449 | |
| Domain | ABC_A | 2.34e-03 | 12 | 114 | 2 | IPR026082 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.61e-03 | 45 | 114 | 3 | IPR018000 | |
| Domain | SPRY | 2.63e-03 | 94 | 114 | 4 | PF00622 | |
| Domain | SPRY_dom | 2.63e-03 | 94 | 114 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 2.74e-03 | 95 | 114 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.74e-03 | 95 | 114 | 4 | PS50188 | |
| Domain | Neur_chan_memb | 2.78e-03 | 46 | 114 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 2.95e-03 | 47 | 114 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.95e-03 | 47 | 114 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 2.95e-03 | 47 | 114 | 3 | IPR006029 | |
| Domain | - | 2.95e-03 | 47 | 114 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 2.95e-03 | 47 | 114 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.95e-03 | 47 | 114 | 3 | IPR006202 | |
| Domain | MFS | 4.33e-03 | 108 | 114 | 4 | PS50850 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 5.42e-09 | 12 | 85 | 5 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 5.42e-09 | 12 | 85 | 5 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 5.42e-09 | 12 | 85 | 5 | MM15443 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 8.77e-09 | 13 | 85 | 5 | M47589 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 8.77e-09 | 13 | 85 | 5 | M27708 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.79e-08 | 147 | 85 | 10 | MM15854 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.03e-08 | 15 | 85 | 5 | M26902 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.32e-08 | 151 | 85 | 10 | M39329 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.93e-08 | 16 | 85 | 5 | M46428 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 5.70e-08 | 18 | 85 | 5 | MM14510 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 1.33e-07 | 21 | 85 | 5 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 1.33e-07 | 21 | 85 | 5 | M199 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.19e-07 | 23 | 85 | 5 | MM15216 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLC29A3 ABCA3 SLC35D2 TRPC1 ANO10 CUBN ABCA8 RYR1 RYR2 SLC38A2 ATP8A1 CLN3 SLC22A2 TRPV4 TRPM8 FTL SLC4A4 | 3.01e-07 | 736 | 85 | 18 | M27287 |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.56e-07 | 154 | 85 | 9 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.97e-07 | 156 | 85 | 9 | M39475 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 4.21e-07 | 26 | 85 | 5 | M247 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLC29A3 ABCA3 SLC35D2 TRPC1 ANO10 ABCA8 RYR1 RYR2 SLC38A2 ATP8A1 CLN3 SLC22A2 TRPV4 TRPM8 FTL SLC4A4 | 5.11e-07 | 681 | 85 | 17 | MM14985 |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 8.44e-07 | 13 | 85 | 4 | M39589 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 8.96e-07 | 30 | 85 | 5 | M17814 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.99e-06 | 35 | 85 | 5 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 2.30e-06 | 36 | 85 | 5 | M271 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 3.94e-06 | 40 | 85 | 5 | MM14473 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.99e-06 | 46 | 85 | 5 | M239 | |
| Pathway | PID_LKB1_PATHWAY | 8.90e-06 | 47 | 85 | 5 | M87 | |
| Pathway | PID_FOXO_PATHWAY | 1.10e-05 | 49 | 85 | 5 | M136 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 1.34e-05 | 51 | 85 | 5 | M7955 | |
| Pathway | PID_NFAT_3PATHWAY | 1.62e-05 | 53 | 85 | 5 | M113 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.94e-05 | 55 | 85 | 5 | M7455 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 2.72e-05 | 98 | 85 | 6 | M46424 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.88e-05 | 99 | 85 | 6 | MM14910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.37e-05 | 11 | 85 | 3 | M47958 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.24e-05 | 106 | 85 | 6 | M27200 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.48e-05 | 12 | 85 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.48e-05 | 12 | 85 | 3 | M27939 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 5.10e-05 | 67 | 85 | 5 | M295 | |
| Pathway | PID_MTOR_4PATHWAY | 5.87e-05 | 69 | 85 | 5 | M121 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 6.07e-05 | 113 | 85 | 6 | M16817 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.21e-05 | 72 | 85 | 5 | M26954 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 7.21e-05 | 72 | 85 | 5 | MM15381 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 7.70e-05 | 73 | 85 | 5 | MM15223 | |
| Pathway | WP_CELL_CYCLE | 8.48e-05 | 120 | 85 | 6 | M39650 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.13e-05 | 176 | 85 | 7 | MM15718 | |
| Pathway | KEGG_CELL_CYCLE | 1.06e-04 | 125 | 85 | 6 | M7963 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.16e-04 | 183 | 85 | 7 | M997 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.19e-04 | 80 | 85 | 5 | M223 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.50e-04 | 84 | 85 | 5 | M27495 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 1.66e-04 | 46 | 85 | 4 | M48105 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.91e-04 | 19 | 85 | 3 | M47760 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 2.22e-04 | 143 | 85 | 6 | MM15383 | |
| Pathway | REACTOME_SARS_COV_1_INFECTION | 2.22e-04 | 143 | 85 | 6 | M39006 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.43e-04 | 93 | 85 | 5 | M27487 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.55e-04 | 94 | 85 | 5 | M1080 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.80e-04 | 211 | 85 | 7 | MM14502 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 3.00e-04 | 22 | 85 | 3 | M39795 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 3.00e-04 | 22 | 85 | 3 | MM15656 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.09e-04 | 54 | 85 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.09e-04 | 54 | 85 | 4 | MM15202 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.93e-04 | 159 | 85 | 6 | M39373 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 4.26e-04 | 105 | 85 | 5 | M164 | |
| Pathway | REACTOME_APOPTOSIS | 4.85e-04 | 108 | 85 | 5 | MM14471 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 5.10e-04 | 167 | 85 | 6 | M19381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE | 5.31e-04 | 6 | 85 | 2 | M47618 | |
| Pathway | REACTOME_TRP_CHANNELS | 6.22e-04 | 28 | 85 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 6.22e-04 | 28 | 85 | 3 | M27241 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 6.68e-04 | 66 | 85 | 4 | MM15925 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 8.34e-04 | 70 | 85 | 4 | M8232 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 9.76e-04 | 126 | 85 | 5 | M16763 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 9.76e-04 | 73 | 85 | 4 | MM16641 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.08e-03 | 129 | 85 | 5 | M186 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.21e-03 | 270 | 85 | 7 | M15514 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.24e-03 | 271 | 85 | 7 | MM15388 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 1.26e-03 | 9 | 85 | 2 | MM1477 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 1.26e-03 | 9 | 85 | 2 | M47732 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.26e-03 | 272 | 85 | 7 | M13380 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.44e-03 | 204 | 85 | 6 | M45011 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.66e-03 | 142 | 85 | 5 | MM15178 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.86e-03 | 291 | 85 | 7 | M16647 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 1.91e-03 | 11 | 85 | 2 | M17668 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 2.16e-03 | 299 | 85 | 7 | M41727 | |
| Pathway | WP_IRON_HOMEOSTASIS | 2.68e-03 | 13 | 85 | 2 | MM15935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 2.68e-03 | 13 | 85 | 2 | M47731 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 3.12e-03 | 14 | 85 | 2 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 3.12e-03 | 14 | 85 | 2 | MM15062 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.33e-03 | 323 | 85 | 7 | M27080 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.46e-03 | 103 | 85 | 4 | MM15196 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 3.59e-03 | 15 | 85 | 2 | MM15019 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.07e-03 | 335 | 85 | 7 | MM14503 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 4.08e-03 | 16 | 85 | 2 | M923 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.41e-03 | 178 | 85 | 5 | M2890 | |
| Pathway | REACTOME_APOPTOSIS | 4.52e-03 | 179 | 85 | 5 | M15303 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 4.52e-03 | 630 | 85 | 10 | M11480 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 4.56e-03 | 257 | 85 | 6 | MM14755 | |
| Pathway | WP_IRON_METABOLISM_DISORDERS | 4.61e-03 | 17 | 85 | 2 | M48053 | |
| Pubmed | 2.91e-12 | 13 | 123 | 6 | 22222486 | ||
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 3.05e-12 | 6 | 123 | 5 | 10713667 | |
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 10441394 | ||
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 1.06e-11 | 7 | 123 | 5 | 15023544 | |
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 1.06e-11 | 7 | 123 | 5 | 36096339 | |
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 27030597 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.06e-11 | 7 | 123 | 5 | 20388496 | |
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 22588126 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.06e-11 | 7 | 123 | 5 | 12383250 | |
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 16868027 | ||
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 31906564 | ||
| Pubmed | 1.06e-11 | 7 | 123 | 5 | 21390248 | ||
| Pubmed | 2.83e-11 | 8 | 123 | 5 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 2.83e-11 | 8 | 123 | 5 | 9524113 | |
| Pubmed | 2.83e-11 | 8 | 123 | 5 | 16045749 | ||
| Pubmed | 2.83e-11 | 8 | 123 | 5 | 18332103 | ||
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 2.83e-11 | 8 | 123 | 5 | 23622247 | |
| Pubmed | 4.52e-11 | 19 | 123 | 6 | 35343654 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 6.35e-11 | 9 | 123 | 5 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 6.35e-11 | 9 | 123 | 5 | 12438239 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 6.35e-11 | 9 | 123 | 5 | 12176984 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 6.35e-11 | 9 | 123 | 5 | 16511560 | |
| Pubmed | 6.35e-11 | 9 | 123 | 5 | 18458160 | ||
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 6.35e-11 | 9 | 123 | 5 | 34294877 | |
| Pubmed | 6.35e-11 | 9 | 123 | 5 | 16581770 | ||
| Pubmed | 6.35e-11 | 9 | 123 | 5 | 12446771 | ||
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 1.27e-10 | 10 | 123 | 5 | 14505491 | |
| Pubmed | 1.27e-10 | 10 | 123 | 5 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 1.27e-10 | 10 | 123 | 5 | 15791647 | |
| Pubmed | 1.27e-10 | 10 | 123 | 5 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 1.27e-10 | 10 | 123 | 5 | 25154416 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 1.27e-10 | 10 | 123 | 5 | 11697890 | |
| Pubmed | 1.49e-10 | 4 | 123 | 4 | 16968670 | ||
| Pubmed | 2.32e-10 | 11 | 123 | 5 | 15696159 | ||
| Pubmed | 3.96e-10 | 12 | 123 | 5 | 39406751 | ||
| Pubmed | 3.96e-10 | 12 | 123 | 5 | 18779327 | ||
| Pubmed | BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. | 3.96e-10 | 12 | 123 | 5 | 29686263 | |
| Pubmed | 3.96e-10 | 12 | 123 | 5 | 20642453 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 3.96e-10 | 12 | 123 | 5 | 19172738 | |
| Pubmed | 6.41e-10 | 13 | 123 | 5 | 19014373 | ||
| Pubmed | 6.41e-10 | 13 | 123 | 5 | 34654719 | ||
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 7.43e-10 | 5 | 123 | 4 | 19173300 | |
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 23938468 | ||
| Pubmed | Structural basis for protein-protein interactions in the 14-3-3 protein family. | 7.43e-10 | 5 | 123 | 4 | 17085597 | |
| Pubmed | A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting with 14-3-3 proteins. | 7.43e-10 | 5 | 123 | 4 | 16775625 | |
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 11985497 | ||
| Pubmed | 14-3-3 Proteins regulate exonuclease 1-dependent processing of stalled replication forks. | 7.43e-10 | 5 | 123 | 4 | 21533173 | |
| Pubmed | 9.95e-10 | 14 | 123 | 5 | 15265780 | ||
| Pubmed | 9.95e-10 | 14 | 123 | 5 | 16093354 | ||
| Pubmed | 9.95e-10 | 14 | 123 | 5 | 12919677 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 9.95e-10 | 14 | 123 | 5 | 36806887 | |
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 9.95e-10 | 14 | 123 | 5 | 33761321 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HFE LARGE2 TMEM67 MLEC TMTC2 LAMP2 PIGU YWHAB YWHAE ELAC2 DEGS1 DIPK2A STT3B ITPR1 SLC38A2 PRMT5 CLPTM1 PKD2 KDELR1 MFSD5 KIF2C | 1.47e-09 | 1201 | 123 | 21 | 35696571 |
| Pubmed | 1.49e-09 | 15 | 123 | 5 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 1.49e-09 | 15 | 123 | 5 | 16041367 | |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 2.16e-09 | 16 | 123 | 5 | 23071090 | |
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 2.22e-09 | 6 | 123 | 4 | 11864996 | |
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 9369453 | ||
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 2.22e-09 | 6 | 123 | 4 | 19860830 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 3.05e-09 | 17 | 123 | 5 | 37045861 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 4.21e-09 | 18 | 123 | 5 | 30240640 | |
| Pubmed | Identification of five novel 14-3-3 isoforms interacting with the GPIb-IX complex in platelets. | 5.17e-09 | 7 | 123 | 4 | 19558434 | |
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 10620507 | ||
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 5.17e-09 | 7 | 123 | 4 | 16679322 | |
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 5.17e-09 | 7 | 123 | 4 | 15883043 | |
| Pubmed | SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. | 5.17e-09 | 7 | 123 | 4 | 19640509 | |
| Pubmed | Analysis of phosphorylation-dependent protein-protein interactions of histone h3. | 9.91e-09 | 21 | 123 | 5 | 25330109 | |
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 36503900 | ||
| Pubmed | Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. | 1.03e-08 | 8 | 123 | 4 | 23075850 | |
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 8702721 | ||
| Pubmed | Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding. | 1.03e-08 | 8 | 123 | 4 | 18356162 | |
| Pubmed | 2.56e-08 | 25 | 123 | 5 | 21145499 | ||
| Pubmed | The structural basis for 14-3-3:phosphopeptide binding specificity. | 4.32e-08 | 3 | 123 | 3 | 9428519 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 8617504 | ||
| Pubmed | Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia. | 4.32e-08 | 3 | 123 | 3 | 27030512 | |
| Pubmed | TRPV4, TRPC1, and TRPP2 assemble to form a flow-sensitive heteromeric channel. | 4.32e-08 | 3 | 123 | 3 | 25114176 | |
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 4.32e-08 | 3 | 123 | 3 | 9986730 | |
| Pubmed | 4.69e-08 | 28 | 123 | 5 | 20012529 | ||
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 7.21e-08 | 12 | 123 | 4 | 29523541 | |
| Pubmed | 1.04e-07 | 13 | 123 | 4 | 23177959 | ||
| Pubmed | 1.12e-07 | 33 | 123 | 5 | 19834762 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 24269678 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9705322 | ||
| Pubmed | Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. | 1.72e-07 | 4 | 123 | 3 | 12507503 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.72e-07 | 4 | 123 | 3 | 23413940 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9607712 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 19120137 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 18059471 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 8515476 | ||
| Pubmed | Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. | 1.72e-07 | 4 | 123 | 3 | 15229649 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.33e-07 | 38 | 123 | 5 | 30786075 | |
| Pubmed | 3.91e-07 | 42 | 123 | 5 | 23444366 | ||
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 4.29e-07 | 5 | 123 | 3 | 9124414 | |
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 4.29e-07 | 5 | 123 | 3 | 9197417 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 14970201 | ||
| Pubmed | 4.96e-07 | 44 | 123 | 5 | 19322198 | ||
| Pubmed | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. | 5.54e-07 | 19 | 123 | 4 | 15142377 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYO1D ACY3 LAMP2 CUBN YWHAE YWHAH YWHAZ RYR1 HSPA12A SLC22A2 PKD2 SNX18 FTL YWHAQ SLC4A4 DOP1B | 6.37e-07 | 1016 | 123 | 16 | 19056867 |
| Pubmed | MLEC ELOVL1 PRPF6 ANO10 PIGU YWHAB YWHAE STT3B ITPR1 ATP8A1 NBEAL2 CLPTM1 MLH1 FTL YWHAQ MFSD5 KIF2C | 8.19e-07 | 1168 | 123 | 17 | 19946888 | |
| Pubmed | Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. | 8.57e-07 | 6 | 123 | 3 | 20224040 | |
| Interaction | KCNK15 interactions | 2.68e-10 | 8 | 112 | 5 | int:KCNK15 | |
| Interaction | KCNK9 interactions | 6.00e-10 | 9 | 112 | 5 | int:KCNK9 | |
| Interaction | OTOG interactions | 1.19e-09 | 10 | 112 | 5 | int:OTOG | |
| Interaction | ATAT1 interactions | 1.79e-09 | 22 | 112 | 6 | int:ATAT1 | |
| Interaction | PACS2 interactions | 3.19e-09 | 24 | 112 | 6 | int:PACS2 | |
| Interaction | PPP1R3E interactions | 3.72e-09 | 12 | 112 | 5 | int:PPP1R3E | |
| Interaction | PLEKHM3 interactions | 5.41e-09 | 26 | 112 | 6 | int:PLEKHM3 | |
| Interaction | KCNK3 interactions | 6.02e-09 | 13 | 112 | 5 | int:KCNK3 | |
| Interaction | CARMIL2 interactions | 8.78e-09 | 28 | 112 | 6 | int:CARMIL2 | |
| Interaction | FRMD6 interactions | 1.69e-08 | 53 | 112 | 7 | int:FRMD6 | |
| Interaction | SAMSN1 interactions | 2.02e-08 | 16 | 112 | 5 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 2.02e-08 | 16 | 112 | 5 | int:TESPA1 | |
| Interaction | ARL14EP interactions | 2.52e-08 | 33 | 112 | 6 | int:ARL14EP | |
| Interaction | ZNF395 interactions | 2.84e-08 | 17 | 112 | 5 | int:ZNF395 | |
| Interaction | KCNQ5 interactions | 3.05e-08 | 34 | 112 | 6 | int:KCNQ5 | |
| Interaction | FAM53B interactions | 3.92e-08 | 18 | 112 | 5 | int:FAM53B | |
| Interaction | FAM163A interactions | 5.29e-08 | 19 | 112 | 5 | int:FAM163A | |
| Interaction | PARP8 interactions | 7.03e-08 | 20 | 112 | 5 | int:PARP8 | |
| Interaction | MLXIP interactions | 7.03e-08 | 20 | 112 | 5 | int:MLXIP | |
| Interaction | SPATA13 interactions | 9.18e-08 | 21 | 112 | 5 | int:SPATA13 | |
| Interaction | SPIRE2 interactions | 9.18e-08 | 21 | 112 | 5 | int:SPIRE2 | |
| Interaction | STOX2 interactions | 9.18e-08 | 21 | 112 | 5 | int:STOX2 | |
| Interaction | DENND1B interactions | 9.18e-08 | 21 | 112 | 5 | int:DENND1B | |
| Interaction | INPP5F interactions | 9.88e-08 | 41 | 112 | 6 | int:INPP5F | |
| Interaction | PPP4R4 interactions | 1.18e-07 | 22 | 112 | 5 | int:PPP4R4 | |
| Interaction | PPP1R3D interactions | 1.18e-07 | 22 | 112 | 5 | int:PPP1R3D | |
| Interaction | SSH2 interactions | 1.33e-07 | 43 | 112 | 6 | int:SSH2 | |
| Interaction | CCSER1 interactions | 1.51e-07 | 23 | 112 | 5 | int:CCSER1 | |
| Interaction | GLCCI1 interactions | 1.51e-07 | 23 | 112 | 5 | int:GLCCI1 | |
| Interaction | BORCS5 interactions | 1.53e-07 | 44 | 112 | 6 | int:BORCS5 | |
| Interaction | E2F8 interactions | 1.89e-07 | 24 | 112 | 5 | int:E2F8 | |
| Interaction | LNP1 interactions | 2.36e-07 | 25 | 112 | 5 | int:LNP1 | |
| Interaction | C6orf132 interactions | 2.36e-07 | 25 | 112 | 5 | int:C6orf132 | |
| Interaction | TMCC1 interactions | 2.36e-07 | 25 | 112 | 5 | int:TMCC1 | |
| Interaction | MAST4 interactions | 2.90e-07 | 26 | 112 | 5 | int:MAST4 | |
| Interaction | FAM83G interactions | 2.90e-07 | 26 | 112 | 5 | int:FAM83G | |
| Interaction | CFAP410 interactions | 2.96e-07 | 49 | 112 | 6 | int:CFAP410 | |
| Interaction | CEP95 interactions | 3.35e-07 | 50 | 112 | 6 | int:CEP95 | |
| Interaction | SPIRE1 interactions | 3.55e-07 | 27 | 112 | 5 | int:SPIRE1 | |
| Interaction | SPATA18 interactions | 4.30e-07 | 28 | 112 | 5 | int:SPATA18 | |
| Interaction | KIAA0930 interactions | 4.30e-07 | 28 | 112 | 5 | int:KIAA0930 | |
| Interaction | USP31 interactions | 4.30e-07 | 28 | 112 | 5 | int:USP31 | |
| Interaction | WWC2 interactions | 4.30e-07 | 28 | 112 | 5 | int:WWC2 | |
| Interaction | DENND2B interactions | 4.30e-07 | 28 | 112 | 5 | int:DENND2B | |
| Interaction | PDE7B interactions | 4.32e-07 | 12 | 112 | 4 | int:PDE7B | |
| Interaction | REM1 interactions | 4.32e-07 | 12 | 112 | 4 | int:REM1 | |
| Interaction | ARHGEF5 interactions | 4.68e-07 | 85 | 112 | 7 | int:ARHGEF5 | |
| Interaction | LYST interactions | 4.78e-07 | 53 | 112 | 6 | int:LYST | |
| Interaction | FAM13A interactions | 5.17e-07 | 29 | 112 | 5 | int:FAM13A | |
| Interaction | WDR20 interactions | 5.94e-07 | 88 | 112 | 7 | int:WDR20 | |
| Interaction | ZFP36L1 interactions | 6.18e-07 | 30 | 112 | 5 | int:ZFP36L1 | |
| Interaction | ARAP2 interactions | 6.18e-07 | 30 | 112 | 5 | int:ARAP2 | |
| Interaction | TICRR interactions | 6.18e-07 | 30 | 112 | 5 | int:TICRR | |
| Interaction | MACIR interactions | 7.34e-07 | 31 | 112 | 5 | int:MACIR | |
| Interaction | ALS2 interactions | 7.34e-07 | 31 | 112 | 5 | int:ALS2 | |
| Interaction | PABIR1 interactions | 7.34e-07 | 31 | 112 | 5 | int:PABIR1 | |
| Interaction | MAP3K9 interactions | 7.34e-07 | 31 | 112 | 5 | int:MAP3K9 | |
| Interaction | CRTC1 interactions | 7.34e-07 | 31 | 112 | 5 | int:CRTC1 | |
| Interaction | EXO1 interactions | 8.24e-07 | 58 | 112 | 6 | int:EXO1 | |
| Interaction | AKT1S1 interactions | 8.66e-07 | 32 | 112 | 5 | int:AKT1S1 | |
| Interaction | CEP112 interactions | 8.66e-07 | 32 | 112 | 5 | int:CEP112 | |
| Interaction | VASH2 interactions | 8.67e-07 | 14 | 112 | 4 | int:VASH2 | |
| Interaction | PI4KB interactions | 1.01e-06 | 60 | 112 | 6 | int:PI4KB | |
| Interaction | CEP85L interactions | 1.02e-06 | 33 | 112 | 5 | int:CEP85L | |
| Interaction | ARHGEF4 interactions | 1.11e-06 | 61 | 112 | 6 | int:ARHGEF4 | |
| Interaction | HOMER1 interactions | 1.15e-06 | 140 | 112 | 8 | int:HOMER1 | |
| Interaction | SLC8A2 interactions | 1.18e-06 | 15 | 112 | 4 | int:SLC8A2 | |
| Interaction | REEP3 interactions | 1.19e-06 | 34 | 112 | 5 | int:REEP3 | |
| Interaction | SMTNL2 interactions | 1.38e-06 | 35 | 112 | 5 | int:SMTNL2 | |
| Interaction | FAM86C1P interactions | 1.38e-06 | 35 | 112 | 5 | int:FAM86C1P | |
| Interaction | PTPN3 interactions | 1.42e-06 | 100 | 112 | 7 | int:PTPN3 | |
| Interaction | PANK2 interactions | 1.83e-06 | 37 | 112 | 5 | int:PANK2 | |
| Interaction | PFKFB4 interactions | 2.10e-06 | 38 | 112 | 5 | int:PFKFB4 | |
| Interaction | TNK1 interactions | 2.10e-06 | 38 | 112 | 5 | int:TNK1 | |
| Interaction | PLEKHG5 interactions | 2.10e-06 | 38 | 112 | 5 | int:PLEKHG5 | |
| Interaction | RUSC2 interactions | 2.10e-06 | 38 | 112 | 5 | int:RUSC2 | |
| Interaction | TMCC3 interactions | 2.40e-06 | 39 | 112 | 5 | int:TMCC3 | |
| Interaction | PRR5 interactions | 2.40e-06 | 39 | 112 | 5 | int:PRR5 | |
| Interaction | PTOV1 interactions | 2.53e-06 | 70 | 112 | 6 | int:PTOV1 | |
| Interaction | FAM117B interactions | 2.73e-06 | 40 | 112 | 5 | int:FAM117B | |
| Interaction | KANK1 interactions | 2.73e-06 | 40 | 112 | 5 | int:KANK1 | |
| Interaction | HECTD4 interactions | 2.73e-06 | 40 | 112 | 5 | int:HECTD4 | |
| Interaction | PABIR2 interactions | 2.73e-06 | 40 | 112 | 5 | int:PABIR2 | |
| Interaction | FGD6 interactions | 2.73e-06 | 40 | 112 | 5 | int:FGD6 | |
| Interaction | NKD2 interactions | 2.73e-06 | 40 | 112 | 5 | int:NKD2 | |
| Interaction | ARHGEF28 interactions | 3.50e-06 | 42 | 112 | 5 | int:ARHGEF28 | |
| Interaction | SYDE2 interactions | 3.94e-06 | 43 | 112 | 5 | int:SYDE2 | |
| Interaction | NAV2 interactions | 3.94e-06 | 43 | 112 | 5 | int:NAV2 | |
| Interaction | SAMD4A interactions | 4.43e-06 | 44 | 112 | 5 | int:SAMD4A | |
| Interaction | IQSEC2 interactions | 4.43e-06 | 44 | 112 | 5 | int:IQSEC2 | |
| Interaction | DMTN interactions | 4.43e-06 | 44 | 112 | 5 | int:DMTN | |
| Interaction | TRAK1 interactions | 4.43e-06 | 77 | 112 | 6 | int:TRAK1 | |
| Interaction | BLTP3B interactions | 4.43e-06 | 77 | 112 | 6 | int:BLTP3B | |
| Interaction | PSD3 interactions | 4.78e-06 | 78 | 112 | 6 | int:PSD3 | |
| Interaction | RAPGEF6 interactions | 4.78e-06 | 78 | 112 | 6 | int:RAPGEF6 | |
| Interaction | ARL6IP6 interactions | 4.78e-06 | 78 | 112 | 6 | int:ARL6IP6 | |
| Interaction | ARL3 interactions | 4.78e-06 | 78 | 112 | 6 | int:ARL3 | |
| Interaction | RADIL interactions | 4.96e-06 | 45 | 112 | 5 | int:RADIL | |
| Interaction | RGS12 interactions | 4.96e-06 | 45 | 112 | 5 | int:RGS12 | |
| Interaction | UAP1 interactions | 4.96e-06 | 45 | 112 | 5 | int:UAP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 6.41e-08 | 271 | 125 | 9 | chr7q11 |
| Cytoband | 7q11.23 | 1.49e-04 | 97 | 125 | 4 | 7q11.23 | |
| Cytoband | 1p36.21 | 6.94e-04 | 63 | 125 | 3 | 1p36.21 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 3.76e-11 | 7 | 83 | 5 | 1053 | |
| GeneFamily | Transient receptor potential cation channels | 7.77e-06 | 28 | 83 | 4 | 249 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 6.23e-05 | 3 | 83 | 2 | 287 | |
| GeneFamily | Lysophosphatidic acid receptors | 3.09e-04 | 6 | 83 | 2 | 205 | |
| GeneFamily | Solute carriers | SLC29A3 SLC35D2 SLCO6A1 SLC38A2 SLC22A2 SLC45A1 SLC4A4 SLC35A5 | 4.57e-04 | 395 | 83 | 8 | 752 |
| GeneFamily | Glycosyltransferase family 8 | 7.34e-04 | 9 | 83 | 2 | 436 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 7.34e-04 | 9 | 83 | 2 | 1230 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.33e-03 | 12 | 83 | 2 | 756 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 1.33e-03 | 12 | 83 | 2 | 445 | |
| GeneFamily | ATP binding cassette subfamily A | 1.83e-03 | 14 | 83 | 2 | 805 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.38e-03 | 19 | 83 | 2 | 563 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 4.13e-03 | 21 | 83 | 2 | 680 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.66e-03 | 181 | 83 | 4 | 694 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.08e-07 | 26 | 119 | 5 | M1380 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.76e-08 | 200 | 121 | 8 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.76e-08 | 200 | 121 | 8 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-06 | 200 | 121 | 7 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-06 | 200 | 121 | 7 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.90e-06 | 180 | 121 | 6 | c3d1521ac90f2e3fc31158e6e61907e05c37af39 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 9.90e-06 | 180 | 121 | 6 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 185 | 121 | 6 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 185 | 121 | 6 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 186 | 121 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 189 | 121 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-05 | 192 | 121 | 6 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 121 | 6 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 200 | 121 | 6 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 131 | 121 | 5 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.61e-05 | 150 | 121 | 5 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 6.36e-05 | 154 | 121 | 5 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-05 | 164 | 121 | 5 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.81e-05 | 165 | 121 | 5 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 167 | 121 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 170 | 121 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 173 | 121 | 5 | 12c6875f881cb0fbff09d753b53c1cce7a95527f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 174 | 121 | 5 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 174 | 121 | 5 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 176 | 121 | 5 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 176 | 121 | 5 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 180 | 121 | 5 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 1.36e-04 | 181 | 121 | 5 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 121 | 5 | 92f54c267135cb5edbcacd26a0f29e62469bb7e5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 121 | 5 | 5c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.47e-04 | 184 | 121 | 5 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 184 | 121 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 186 | 121 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 1.58e-04 | 187 | 121 | 5 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 187 | 121 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 188 | 121 | 5 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 188 | 121 | 5 | d00f48afed62fc60d3530bb3b80ac0162b0b0ed8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-04 | 188 | 121 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 189 | 121 | 5 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 189 | 121 | 5 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 190 | 121 | 5 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.70e-04 | 190 | 121 | 5 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 190 | 121 | 5 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 191 | 121 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 191 | 121 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.79e-04 | 192 | 121 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 192 | 121 | 5 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(4)_1wkpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.79e-04 | 103 | 121 | 4 | 942cc6f9699f777638e59aee40a402a16fdbb2e7 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Tmem2_(Tmem2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.79e-04 | 103 | 121 | 4 | 287e945ef2f9646f1ff4a4c50fe6e8a5e7fe0d92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.83e-04 | 193 | 121 | 5 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.83e-04 | 193 | 121 | 5 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 194 | 121 | 5 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 194 | 121 | 5 | 61b59f8e2c68851d827b058cf03904f8125e8047 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-04 | 195 | 121 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 196 | 121 | 5 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-04 | 197 | 121 | 5 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 198 | 121 | 5 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 198 | 121 | 5 | 72733b6149b797ac11cc108bc80428b77fbbba78 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 198 | 121 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 198 | 121 | 5 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 198 | 121 | 5 | f23559ce6072e3c323f6791ff95269271b0f7ff1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.16e-04 | 200 | 121 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 200 | 121 | 5 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 200 | 121 | 5 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 200 | 121 | 5 | e118d5e6e5d5bb808877a6667668c36f21afad5b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-04 | 200 | 121 | 5 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 200 | 121 | 5 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-04 | 200 | 121 | 5 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 200 | 121 | 5 | 234e5a927eec0e235226586451ba3754c8a14169 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 200 | 121 | 5 | 829978708463a7459fe1041bd90196775bc4b531 | |
| Computational | Ion channels. | 4.48e-06 | 70 | 67 | 6 | MODULE_316 | |
| Computational | Neurotransmitter (GABA) receptor. | 9.98e-05 | 15 | 67 | 3 | MODULE_215 | |
| Drug | riluzole | 2.94e-07 | 174 | 117 | 9 | CID000005070 | |
| Drug | CNS 1145 | 6.96e-07 | 33 | 117 | 5 | CID000190902 | |
| Drug | IHC-64 | 6.96e-07 | 33 | 117 | 5 | CID000162753 | |
| Drug | amiloride | CACNA1A TRPC1 NDFIP2 PRPF6 PKDREJ RYR1 GLRA2 PKD2 TRPV4 SLC4A4 NSMAF | 7.05e-07 | 315 | 117 | 11 | CID000016230 |
| Drug | lercanidipine | 8.66e-07 | 63 | 117 | 6 | CID000065866 | |
| Drug | gallopamil | 1.25e-06 | 67 | 117 | 6 | CID000001234 | |
| Drug | AC1L98DX | 1.44e-06 | 38 | 117 | 5 | CID000439957 | |
| Drug | ethosuximide | 2.26e-06 | 74 | 117 | 6 | CID000003291 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 4.56e-06 | 7 | 117 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 4.56e-06 | 7 | 117 | 3 | CID003081001 | |
| Drug | baclofen | 6.62e-06 | 191 | 117 | 8 | CID000002284 | |
| Drug | Flumazenil | 7.27e-06 | 8 | 117 | 3 | ctd:D005442 | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A | 8.00e-06 | 196 | 117 | 8 | 412_DN | |
| Drug | gadolinium | 8.94e-06 | 199 | 117 | 8 | CID000023982 | |
| Drug | manidipine | 9.69e-06 | 95 | 117 | 6 | CID000004008 | |
| Drug | Cinildipine | 1.02e-05 | 56 | 117 | 5 | CID000002752 | |
| Drug | isotetrandrine | 1.09e-05 | 97 | 117 | 6 | CID000005422 | |
| Drug | C13932 | 1.15e-05 | 206 | 117 | 8 | CID000168297 | |
| Drug | borate | 1.16e-05 | 98 | 117 | 6 | CID000007628 | |
| Drug | Bicuculline | 1.42e-05 | 29 | 117 | 4 | ctd:D001640 | |
| Drug | nilvadipine | 1.43e-05 | 60 | 117 | 5 | CID000004494 | |
| Drug | PCB 95 | 1.55e-05 | 10 | 117 | 3 | CID000038012 | |
| Drug | IAA-94 | 1.55e-05 | 61 | 117 | 5 | CID000003667 | |
| Drug | PCB 66 | 2.12e-05 | 11 | 117 | 3 | CID000036185 | |
| Drug | R 478 | 2.12e-05 | 11 | 117 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.12e-05 | 11 | 117 | 3 | CID003081323 | |
| Drug | AC1L1DXE | 2.46e-05 | 299 | 117 | 9 | CID000002548 | |
| Drug | gabapentin | 2.74e-05 | 169 | 117 | 7 | CID000003446 | |
| Drug | AC1L2AC7 | 2.84e-05 | 69 | 117 | 5 | CID000068733 | |
| Drug | cytochalasin B; Up 200; 20.8uM; MCF7; HT_HG-U133A_EA | 3.18e-05 | 173 | 117 | 7 | 1122_UP | |
| Drug | glutamate | GABRB1 GABRB3 CACNA1A TRPC1 ACY3 GRIA3 ACTRT2 RYR1 RYR2 ITPR1 SLC38A2 GLRA2 PKD2 TRPV4 TRPM8 SLC4A4 | 3.35e-05 | 962 | 117 | 16 | CID000000611 |
| Drug | gamma-aminobutyric acid | GABRB1 GABRB3 CACNA1A GRIA3 SYNPR RYR1 RYR2 ITPR1 SLC38A2 GLRA2 PKD2 | 3.39e-05 | 474 | 117 | 11 | CID000000119 |
| Drug | dimethyltin | 3.64e-05 | 13 | 117 | 3 | CID000031651 | |
| Drug | CAS 298-57-7 | 3.74e-05 | 73 | 117 | 5 | CID000002761 | |
| Drug | NAADP | 4.74e-05 | 39 | 117 | 4 | CID000123952 | |
| Drug | nisoldipine | 5.15e-05 | 78 | 117 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 5.47e-05 | 79 | 117 | 5 | CID005287890 | |
| Drug | AC1L1B8E | 5.75e-05 | 15 | 117 | 3 | CID000001327 | |
| Drug | Gvapspat amide | 5.75e-05 | 15 | 117 | 3 | CID000125015 | |
| Drug | 5 beta-alphaxalone | 6.38e-05 | 42 | 117 | 4 | CID000068930 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 3727_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 7138_DN | |
| Drug | XeC compound | 7.34e-05 | 84 | 117 | 5 | CID000005701 | |
| Drug | lanthanum | 7.39e-05 | 136 | 117 | 6 | CID000023926 | |
| Drug | cis-diammineplatinum(II | 7.83e-05 | 3 | 117 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 7.83e-05 | 3 | 117 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 7.83e-05 | 3 | 117 | 2 | CID000127713 | |
| Drug | aminodantrolene | 7.83e-05 | 3 | 117 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 7.83e-05 | 3 | 117 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 7.83e-05 | 3 | 117 | 2 | CID005748312 | |
| Drug | zolpidem | 8.53e-05 | 17 | 117 | 3 | ctd:C049109 | |
| Drug | thymol | 9.15e-05 | 46 | 117 | 4 | CID000006989 | |
| Drug | nicardipine | 1.05e-04 | 145 | 117 | 6 | CID000004473 | |
| Drug | tyrosinate | 1.18e-04 | 148 | 117 | 6 | CID000001153 | |
| Drug | Baclofen | 1.41e-04 | 20 | 117 | 3 | ctd:D001418 | |
| Drug | N-methyl-DL-aspartic acid | GABRB1 GABRB3 CACNA1A TRPC1 GRIA3 YWHAH RYR1 RYR2 ITPR1 CLN3 GLRA2 PKD2 | 1.42e-04 | 655 | 117 | 12 | CID000004376 |
| Drug | lindane | 1.46e-04 | 154 | 117 | 6 | CID000000727 | |
| Drug | nitrendipine | 1.53e-04 | 98 | 117 | 5 | CID000004507 | |
| Drug | PCB74 | 1.56e-04 | 4 | 117 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 1.56e-04 | 4 | 117 | 2 | CID006444275 | |
| Drug | SC 38249 | 1.56e-04 | 4 | 117 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.56e-04 | 4 | 117 | 2 | CID000035682 | |
| Drug | isradipine | 1.68e-04 | 100 | 117 | 5 | CID000003784 | |
| Drug | cyclothiazide | 1.93e-04 | 103 | 117 | 5 | CID000002910 | |
| Drug | loperamide | 2.11e-04 | 105 | 117 | 5 | CID000003954 | |
| Drug | halothane | 2.22e-04 | 314 | 117 | 8 | CID000003562 | |
| Disease | Autism Spectrum Disorders | 1.85e-05 | 85 | 112 | 5 | C1510586 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 4.27e-05 | 3 | 112 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 4.27e-05 | 3 | 112 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | GABRB1 TDRD15 TSPAN18 MLEC FZD3 ACY3 SLCO6A1 SLC38A2 HSPA12A SLC22A2 TRPM8 YWHAQ MOGAT3 | 6.26e-05 | 945 | 112 | 13 | EFO_0005653 |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 2.12e-04 | 6 | 112 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | Akinetic Petit Mal | 2.96e-04 | 7 | 112 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 2.96e-04 | 7 | 112 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 2.96e-04 | 7 | 112 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 2.96e-04 | 7 | 112 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 2.96e-04 | 7 | 112 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 2.96e-04 | 7 | 112 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 2.96e-04 | 7 | 112 | 2 | C0014553 | |
| Disease | Bipolar Disorder | 4.82e-04 | 477 | 112 | 8 | C0005586 | |
| Disease | Dental enamel hypoplasia | 9.19e-04 | 12 | 112 | 2 | EFO_1001304 | |
| Disease | Congenital muscular dystrophy | 9.19e-04 | 12 | 112 | 2 | cv:C0699743 | |
| Disease | Nephronophthisis | 1.08e-03 | 13 | 112 | 2 | C0687120 | |
| Disease | Schizophrenia | GABRB1 GABRB3 TSPAN18 FZD3 GRIA3 YWHAE LPAR1 SLC38A2 SETDB1 HSPA12A | 1.99e-03 | 883 | 112 | 10 | C0036341 |
| Disease | neuritic plaque measurement | 2.19e-03 | 349 | 112 | 6 | EFO_0006798 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.30e-03 | 145 | 112 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.52e-03 | 71 | 112 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.95e-03 | 75 | 112 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Sarcosine measurement | 3.43e-03 | 23 | 112 | 2 | EFO_0021668 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.54e-03 | 80 | 112 | 3 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELFLAFGYERELYVS | 236 | A0A0G2JMD5 | |
| AVFAFLYSLAATVVY | 86 | Q8TBG9 | |
| LGLALNFSVFYYEIL | 171 | P62258 | |
| FYGASVAYENALRVF | 1586 | O00555 | |
| GLALNFSVFYYEILN | 171 | P31946 | |
| IRLGLALNFSVFYYE | 166 | P27348 | |
| VFLDYEAGELSFFNV | 451 | Q6UXG8 | |
| VFINEAAYYEKGVAF | 281 | Q96HD9 | |
| IRLGLALNFSVFYYE | 171 | Q04917 | |
| FYLSDQAVLALYASA | 136 | Q8TDY3 | |
| ILFDNLTVAEHLYFY | 616 | Q99758 | |
| ILQFLTNYFYDVEAL | 41 | Q9NW81 | |
| VGLFFVNVLILYYAF | 31 | O95424 | |
| YALTFGVRQYFLDLA | 751 | Q9Y2Q0 | |
| DYLLLGNFVYTFVVI | 976 | Q9Y2Q0 | |
| FALYGAIEQYNALDE | 66 | Q5RL73 | |
| FALALFGNALVFYVV | 56 | Q96P65 | |
| FRNFYLTFLEYDGNL | 356 | Q8N3Y3 | |
| YLGTFDDYLELFLQF | 491 | Q9NW15 | |
| DDYLELFLQFGYVSL | 496 | Q9NW15 | |
| NTNYGVLLIEFFELY | 306 | Q8NDF8 | |
| FFRNLYLTFLEYDGN | 396 | O95461 | |
| YYAAIKNDEFISFVG | 1231 | O00370 | |
| FGALNIYLDIIYIFT | 291 | Q9BWQ8 | |
| LYYSNFVLALEERFG | 301 | Q8NBP5 | |
| EVVNLARNLIYFGFY | 866 | Q14643 | |
| LAEAFAIYQSLPYFE | 161 | Q5VWC8 | |
| AAFEVAFLVGQYLLY | 221 | Q5T442 | |
| YVLVLKFAEVYFAQS | 121 | Q14165 | |
| YLSLGFYFDRDDVAL | 31 | P02792 | |
| VGNLFLEVIRAFYSY | 381 | Q9Y3R5 | |
| DAVYNAVGLAAYELF | 451 | Q9UI26 | |
| LAAADFFAGLAYFYL | 91 | Q92633 | |
| AYEKFFLLLAEFNSA | 291 | Q92633 | |
| FVYLYDTERGFSILQ | 161 | P42263 | |
| LYLNGTDVLFILFSY | 206 | Q8NGJ9 | |
| QLREAFGDLALFFYD | 1061 | Q9H6R4 | |
| YYLLANLAAADFFAG | 66 | Q9UBY5 | |
| YLDFVFAVKNENRFY | 281 | P13473 | |
| FVFLALLEYAFVNYI | 316 | P18505 | |
| FVFLALLEYAFVNYI | 316 | P28472 | |
| FIFYGDLVYLDFRNN | 76 | Q5VT99 | |
| LEIFAYALQYFKEQA | 166 | O43301 | |
| LFEALGYVDDQLFVF | 46 | Q30201 | |
| YSVYADFILLGLFSN | 6 | Q8NH04 | |
| VGQILLISDYFYAFL | 396 | Q9H490 | |
| LEAVGAYQYVLTFLF | 21 | Q86VF5 | |
| GYFSSEQVVDLLRYF | 31 | Q86XN7 | |
| TGVLYALRSFDYEQF | 511 | Q9Y5H0 | |
| ILIVRFSDYFTGYFN | 276 | Q9NV92 | |
| AYEGFLINYEAISAA | 1031 | O60494 | |
| NYALIAEVILYSEGF | 1601 | Q9C0G6 | |
| YKSALFNELYFLADG | 476 | Q9HCG7 | |
| DQAFVAYENYLLVFI | 181 | Q7L775 | |
| FALYLLDVSFDNFAV | 281 | Q8NDZ4 | |
| VAQVTFDILIYYFLG | 191 | O15121 | |
| FAGYFETVLYQDITL | 551 | O14744 | |
| NFSLVALSLYIVYEF | 66 | Q9BW60 | |
| LFVFAALLEYAAVNF | 326 | P23416 | |
| VDYEFALLFLVFNEN | 921 | Q6MZM0 | |
| CFVGLYDVDALRYFV | 361 | Q9NPG1 | |
| FSLLLLNLEEYYFEQ | 21 | Q92636 | |
| DAFLEGYVQQFLYTF | 1266 | Q76NI1 | |
| AVVFTARYLDLFTNY | 41 | P24390 | |
| ENEALLLRFKYYSFF | 266 | Q96AC1 | |
| LAGDNIYLDFFYSAL | 371 | O15244 | |
| IYAFSAAFYSAILEK | 616 | Q9Y2W3 | |
| YLDFLRFAVFVNGES | 2331 | P21817 | |
| AFAINFILLFYKVSD | 4571 | P21817 | |
| FAYSFLQQLIRYVDE | 2921 | Q92736 | |
| EVYVTFFEIYNGKLF | 396 | Q99661 | |
| FQLDFYQVYFLALAA | 41 | Q6N075 | |
| TGVLYALRSFDYEQF | 511 | Q9Y5H4 | |
| VKFLVYYAGDLANVF | 561 | Q5HYA8 | |
| YYAGDLANVFFIITV | 566 | Q5HYA8 | |
| GSDILNYFESYLAVA | 96 | Q9BZD2 | |
| YLQLSLEEAFFLVYA | 296 | Q8NCE0 | |
| EGYIFVFLNDIFTAA | 171 | Q76EJ3 | |
| AIAAYLACVLFAVFF | 281 | Q9NX52 | |
| EAAYIAFIAYVLNPS | 481 | B5MCY1 | |
| LECARAIYAYALQVF | 556 | O94906 | |
| SVDDLQYFLIGLYTF | 36 | Q15761 | |
| ADFYAAYINILLGVF | 201 | O43913 | |
| ASAEIYLYVAILIFF | 1961 | Q9NTG1 | |
| SALELFFIDQANYFL | 1986 | Q6ZNJ1 | |
| FLSAQLRYFSLYEVA | 726 | Q9Y6C5 | |
| YQRIHFFLALYLAND | 156 | P0DUX0 | |
| YQRIHFFLALYLAND | 156 | P0DTA3 | |
| YQRIHFFLALYLAND | 156 | P0DUD1 | |
| YDISSGLVAIFIAFY | 151 | Q86UG4 | |
| YDSLLQAIAFYELAV | 341 | Q96QE5 | |
| YAIQLEFAGDYVNAL | 781 | Q8NEZ3 | |
| FSIYILNLAAADFLF | 61 | Q96LB2 | |
| YQILIYDFANFGVLR | 561 | P40692 | |
| FNYFTLGVDILFDAN | 286 | Q9BSU1 | |
| FVLDFEAGILQYFVN | 96 | Q9BXB5 | |
| ISFAYYGVILASAEL | 291 | Q8N434 | |
| LRFLIFFDDGYASYV | 291 | Q15047 | |
| AFDTCLYLALAIYFE | 406 | O94911 | |
| IRLGLALNFSVFYYE | 166 | P63104 | |
| VYFAEYFINQGLFEL | 291 | Q13286 | |
| YKALNTFIDDLFAFV | 546 | O96005 | |
| LFFFLRDVVYNYITE | 31 | A4QN01 | |
| LVAEGLFAFANVLSY | 496 | P48995 | |
| GAALYVFSEFNRYLF | 71 | Q9BQ52 | |
| AFLYFLDNLIVFYVL | 101 | Q9BS91 | |
| LAALFGYLTFYEHVE | 341 | Q96QD8 | |
| YQRIHFFLALYLAND | 156 | P0DUX1 | |
| YQRIHFFLALYLAND | 156 | A0A494C0Z2 | |
| YQRIHFFLALYLAND | 156 | P0DUD3 | |
| YQRIHFFLALYLAND | 156 | P0DUD4 | |
| YQRIHFFLALYLAND | 156 | P0DUD2 | |
| DNEGIAIFALQFTYY | 221 | Q8TCJ2 | |
| FQFLYTYIAKVDGEI | 161 | Q9HAT0 | |
| FLLEYLALGNEYSFS | 601 | Q96RF0 | |
| LFFYVGFVIAERVLY | 411 | Q8N394 | |
| ELFLAFGYERELYVS | 236 | O60809 | |
| YDIGLFAYFFLRENA | 291 | Q9P283 | |
| VLAFLASAFLVVDAY | 76 | A8MWL6 | |
| IIFLAYAQLAYLVFG | 606 | Q13563 | |
| YAQLAYLVFGTQVDD | 611 | Q13563 | |
| YFLQDAFQLRYLDLS | 741 | Q9NYK1 | |
| ILNTFETYVYLAGAL | 211 | Q96SJ8 | |
| FFASDFYDALNIQAL | 456 | Q9Y6R1 | |
| YQRIHFFLALYLAND | 156 | A0A494C191 | |
| VFNLANLEVEAALYY | 331 | A2RRH5 | |
| NVVFYIAFLLLFAYV | 741 | Q7Z2W7 | |
| ELKQYGFFSYLRELF | 556 | Q8IY18 | |
| FLARVALVFYGVFQD | 26 | Q9H3S5 | |
| LLSAVSFAYYRDLVF | 301 | Q9H3S5 | |
| DGSFQLLYFIYSVLV | 546 | Q9HBA0 | |
| VAFYDGRSLDLLYAF | 376 | Q9H2S5 | |
| VLDIYGFEIFDNNSF | 381 | O94832 | |
| LSFEEFQNYFADGVL | 56 | Q96P71 |